Highly Stereocontrolled Synthesis of Azeto[1,2-a]pyrimidines
FULL PAPER
Compound 8a: 0.29 g, 42%. IR (nujol): ν˜ ϭ 1663 (CϭN) cmϪ1. H
1
cular [2ϩ2] cycloaddition between ketenimine and imine
functions to yield 2-iminoazetidines. This methodology has
now allowed us to prepare different types of azeto[1,2-a]-
pyrimidines, either isolated or fused to a thiazole ring, with
excellent diastereoselectivity in the newly formed CϪC
bond, when applicable.
NMR (300 MHz, CDCl3, 25 °C): δ ϭ 3.98 (dd, J ϭ 12.8, 3.1 Hz,
1 H), 4.04 (dd, J ϭ 12.8, 3.1 Hz, 1 H), 5.30 (s, 1 H), 5.38 (t, J ϭ
3.1 Hz, 1 H), 6.92Ϫ6.95 (m, 6 H), 7.05Ϫ7.08 (m, 2 H), 7.18Ϫ7.32
(m, 7 H), 7.67 (d, J ϭ 7.6 Hz, 2 H), 7.74 (d, J ϭ 7.6 Hz, 2 H) ppm.
13C NMR (75 MHz, CDCl3, 25 °C): δ ϭ 42.6, 70.6 (s), 73.8, 100.4,
125.6, 126.9, 127.3, 127.8, 128.0, 128.2, 128.7, 129.4, 131.5, 132.5
(s), 134.5 (s), 138.0 (s), 139.4 (s), 141.7 (s), 144.3 (s), 165.4 (s) ppm.
MS (70 eV, EI): m/z (%) ϭ 492 (24) [Mϩ, for 81Br], 490 (26) [Mϩ,
for 79Br], 165 (100). C30H23BrN2 (491.42): calcd. C 73.32, H 4.72,
N 5.70; found C 73.19, H 4.79, N 5.59.
Experimental Section
General Remarks: All melting points were determined with a Kofler
hot-plate melting-point apparatus and are uncorrected. IR spectra
were obtained as Nujol emulsions or films with a Nicolet Impact
400 spectrophotometer. 1H and 13C NMR spectra were recorded
with a Bruker AC 200 or a Varian Unity 300 spectrometer and are
reported in ppm on the δ scale. The signal of the solvent was used
as reference. Mass spectra were recorded with a HewlettϪPackard
5993C spectrometer. Microanalyses were performed with a Carlo
Erba EA-1108 instrument. (Z)-3-Azido-3-phenyl-2-propen-1-ol,[11]
4-azido-5-formyl-2-phenylthiazole,[23] diphenyl ketene[24] and
methyl phenyl ketene[25] were prepared by literature procedures. Al-
dimines 5 and 14 were obtained by standard procedures.[12]
Compound 8b: 0.25 g, 39%. IR (nujol): ν˜ ϭ 1673 (CϭN), 1521
(NO2), 1349 (NO2) cmϪ1. 1H NMR (300 MHz, CDCl3, 25 °C): δ ϭ
4.16Ϫ4.17 (m, 2 H), 5.53 (t, J ϭ 3.3 Hz, 1 H), 5.55 (s, 1 H),
6.99Ϫ7.03 (m, 3 H), 7.10Ϫ7.13 (m, 2 H), 7.31Ϫ7.45 (m, 8 H), 7.78
(d, J ϭ 7.2 Hz, 2 H), 7.83 (d, J ϭ 7.2 Hz, 2 H), 8.04 (d, J ϭ 8.7 Hz,
2 H) ppm. 13C NMR (75 MHz, CDCl3, 25 °C): δ ϭ 42.8, 71.3 (s),
73.1, 100.5, 123.4, 125.5, 127.2, 127.6, 127.8, 127.9, 128.0, 128.1,
128.2, 128.4, 128.7, 137.4 (s), 139.0 (s), 141.0 (s), 143.1 (s), 144.1
(s), 147.6 (s), 164.9 (s) ppm. MS (70 eV, EI): m/z (%) ϭ 457 (59)
[Mϩ], 321 (100). C30H23N3O2 (457.52): calcd. C 78.75, H 5.07, N
9.18; found C 78.69, H 5.15, N 9.10.
1
Compound 8c: 0.11 g, 20%. IR (nujol): ν˜ ϭ 1670 (CϭN) cmϪ1. H
Amine 4: Diethyl azodicarboxylate (1.5 g, 8.57 mmol) was added at
0 °C to a solution of triphenylphosphane (2.25 g, 8.57 mmol) in
dry THF (15 mL) and the reaction mixture was stirred for 30 min.
A solution of 3 (1 g, 5.71 mmol) in dry THF (10 mL) and phthali-
mide (1.26 g, 8.57 mmol) were then added. The mixture was stirred
for 1 h at 0 °C and for 36 h at room temperature. The solvent was
removed under reduced pressure and the residue was chromato-
graphed [silica gel, hexanes/EtOAc (4:1, v/v)] to give N-[(Z)-3-az-
ido-3-phenyl-2-propen-1-yl]phthalimide as a colorless oil (1.15 g,
68%). Hydrazine hydrate (7.5 equiv.) was then added to a solution
of the N-[(Z)-3-azido-3-phenyl-2-propen-1-yl]phthalimide (1 g,
3.29 mmol) in a mixture of THF (40 mL) and EtOH (6 mL), and
the reaction mixture was stirred for 16 h at room temperature and
for 2 h at 50 °C. After cooling, the mixture was filtered, the solid
was washed with THF (10 mL), and the solvent was removed from
the filtrate. The resulting material was purified by column chroma-
tography [silica gel, Et2O/EtOH (1:1, v/v)] to yield amine 4 as a
yellow oil (0.27 g, 48%). IR (neat): ν˜ ϭ 3376 (NH2), 3314 (NH2),
2112 (N3) cmϪ1. 1H NMR (200 MHz, CDCl3, 25 °C): δ ϭ 1.48 (br.
s, 2 H), 3.50 (d, J ϭ 6.8 Hz, 2 H), 5.27 (t, J ϭ 6.8 Hz, 1 H), 7.39
(s, 5 H) ppm. 13C NMR (50 MHz, CDCl3, 25 °C): δ ϭ 38.6, 120.9,
127.0, 128.7, 128.9, 134.6 (s), 137.5 (s) ppm. MS (70 eV, EI): m/z
(%) ϭ 174 (30) [Mϩ], 146 (100) [Mϩ Ϫ N2]. C9H10N4 (174.20):
calcd. C 62.05, H 5.79, N 32.16; found C 62.25, H 5.71, N 32.04.
NMR (300 MHz, CDCl3, 25 °C): δ ϭ 4.01 (dd, J ϭ 12.0, 3.1 Hz,
1 H), 4.05 (dd, J ϭ 12.0, 3.1 Hz, 1 H), 5.29 (s, 1 H), 5.38 (t, J ϭ
3.1 Hz, 1 H), 5.83Ϫ5.84 (m, 1 H), 7.03Ϫ7.34 (m, 13 H), 7.62Ϫ7.66
(m, 2 H), 7.72Ϫ7.77 (m, 2 H) ppm. 13C NMR (75 MHz, CDCl3,
25 °C): δ ϭ 42.4, 67.0, 100.5, 109.6, 121.4 (s), 125.6, 127.0, 127.3,
127.7, 128.1, 128.2, 128.3, 128.6, 138.7 (s), 139.5 (s), 141.3, 141.8
(s), 143.4, 144.4 (s), 165.4 (s) ppm. MS (70 eV, EI): m/z (%) ϭ 402
(65) [Mϩ], 114 (100). C28H22N2O (402.49): calcd. C 83.56, H 5.51,
N 6.96; found C 83.48, H 5.42, N 6.85.
Compound 8d: 0.23 g, 34%. IR (nujol): ν˜ ϭ 1665 (CϭN), 1521
(NO2), 1345 (NO2) cmϪ1. 1H NMR (300 MHz, CDCl3, 25 °C): δ ϭ
4.18 (dd, J ϭ 12.8, 2.9 Hz, 1 H), 4.28 (dd, J ϭ 12.8, 2.9 Hz, 1 H),
5.03 (d, J ϭ 8.0 Hz, 1 H), 5.47 (t, J ϭ 2.9 Hz, 1 H), 5.74 (dd, J ϭ
15.7, 8.0 Hz, 1 H), 7.00 (dd, J ϭ 7.5, 1.3 Hz, 1 H), 7.18Ϫ7.50 (m,
14 H), 7.71 (d, J ϭ 7.3 Hz, 2 H), 7.80 (d, J ϭ 6.8 Hz, 2 H), 7.95
(dd, J ϭ 8.1, 1.3 Hz, 1 H) ppm. 13C NMR (75 MHz, CDCl3, 25
°C): δ ϭ 42.7, 69.0 (s), 72.3, 100.6, 124.7, 125.6, 127.3, 127.5, 127.7,
127.8, 128.2, 128.4, 128.5, 128.7, 129.2, 130.2, 131.7, 132.3 (s),
133.4, 138.6 (s), 139.5 (s), 141.2 (s), 144.4 (s), 147.6 (s), 165.0 (s)
ppm. MS (70 eV, EI): m/z (%) ϭ 483 (8) [Mϩ], 164 (100).
C32H25N3O2 (483.56): calcd. C 79.48, H 5.21, N 8.69; found C
79.33, H 5.10, N 8.83.
1
Compound 8e: 0.36 g, 60%. IR (nujol): ν˜ ϭ 1668 (CϭN) cmϪ1. H
General Procedure for the Preparation of the 7-Methyl(phenyl)-2,7-
diphenyl-6,7-dihydro-4H-azeto[1,2-a]pyrimidines (8): Trimethylpho-
sphane (1.4 mmol, 1.4 mL of a 1 toluene solution) was added to a
solution of the corresponding aldimine 5 (1.4 mmol) in dry toluene
(10 mL) and the reaction mixture was stirred at room temperature
until the evolution of nitrogen ceased (30 min). A solution of di-
phenyl ketene or methyl phenyl ketene (1.4 mmol) in the same solv-
ent (2 mL) was then added. After the mixture had been stirred at
room temperature for 30 min, the solvent was removed under re-
duced pressure and the resulting material was chromatographed on
a silica gel column, with hexanes/EtOAc as eluent. After removal
of the solvent from the relevant column chromatography fractions
under reduced pressure, the resulting solid material was triturated,
dried at room temperature under high vacuum for 12 h, and used
as such for characterization. Compounds 8 were stored in the dark
at 0 °C.
NMR (300 MHz, CDCl3, 25 °C): δ ϭ 1.87 (s, 3 H), 4.02 (d, J ϭ
3.3 Hz, 2 H), 4.59 (s, 1 H), 5.39 (t, J ϭ 3.3 Hz, 1 H), 6.80 (d, J ϭ
8.3 Hz, 2 H), 6.95Ϫ7.00 (m, 5 H), 7.17 (d, J ϭ 8.3 Hz, 2 H), 7.21
(d, J ϭ 6.8 Hz, 1 H), 7.28 (t, J ϭ 7.1 Hz, 2 H), 7.69 (d, J ϭ 7.3 Hz,
2 H) ppm. 13C NMR (75 MHz, CDCl3, 25 °C): δ ϭ 24.6, 42.4, 63.1
(s), 75.3, 100.5, 121.9 (s), 125.5, 126.7, 127.2, 127.7, 128.0, 128.1,
128.9, 131.2, 134.7 (s), 138.2 (s), 139.3 (s), 144.3 (s), 167.0 (s) ppm.
MS (70 eV, EI): m/z (%) ϭ 430 (40) [Mϩ, for 81Br], 429 (27), 428
(43) [Mϩ, for 79Br], 105 (100). C25H21BrN2 (429.35): calcd. C 69.94,
H 4.93, N 6.52; found C 69.75, H 4.99, N 6.64.
1
Compound 8f: 0.26 g, 48%. IR (nujol): ν˜ ϭ 1659 (CϭN) cmϪ1. H
NMR (300 MHz, CDCl3, 25 °C): δ ϭ 1.85 (s, 3 H), 4.00 (d, J ϭ
3.3 Hz, 2 H), 4.59 (s, 1 H), 5.38 (t, J ϭ 3.3 Hz, 1 H), 6.84 (d, J ϭ
8.7 Hz, 2 H), 6.93Ϫ7.03 (m, 6 H), 7.20Ϫ7.29 (m, 4 H), 7.67Ϫ7.70
(m, 2 H) ppm. 13C NMR (75 MHz, CDCl3, 25 °C): δ ϭ 24.6, 42.5,
Eur. J. Org. Chem. 2002, 4222Ϫ4227
4225